Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 1 EP application Karin Norvin Nilsson has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after January 18, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP13776782

LIQUID PHARMACEUTICAL COMPOSITION OF FACTOR VII POLYPEPTIDE

IPC classification:
A61K 31/4184, A61K 38/37, A61P 7/04
Applicant:
Novo Nordisk Health Care AG
Agent:
Karin Norvin Nilsson, Novo Nordisk A/S
Status:
APPLICATION WITHDRAWN

Please Sign in to use this feature